Loading clinical trials...
Loading clinical trials...
HIV patients are likely to suffer from opportunistic infections, in absence of highly active retroviral therapy. This happens due to lack of awareness of HIV status among patients or unresponsive to a...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Singh, Ranjan Kumar, M.D.
NCT04923958 · Tuberculosis
NCT06590428 · Rifampin-resistant Tuberculosis, Drug-resistant Tuberculosis
NCT06694805 · HIV Infections
NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more
NCT06192160 · Pulmonary Tuberculosis
ART centre, Sadar Hospital
Khagaria, Bihar
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions